Novel material forms can differ radically from their macroscale counterparts
Evidence
The FDA’s assumption of nanoand macroscale equivalence, for instance, is dubious: Scientists believe that nanoparticles are potentially revolutionary as industrial inputs precisely because they display marked differences in chemical and physical behavior as compared to their macroscale equivalents. — Douglas A. Kysar, Regulating from Nowhere, 246
Categorization
- XREF: connects to: Projects of present preferences onto future generations fail because future contexts will differ radically. — Douglas A. Kysar, Regulating from Nowhere: Environmental…, 446